Johnson & Johnson

Healthcare

Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus

Photo via Image courtesy of Genmab, All rights reserved. © 2024 Genmab A/S

BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”

2 min read

Photo via imageBROKER/Marvin Samuel TOLENT/Newscom

Healthcare

Tylenol-Maker’s Shares Sink amid Autism Scrutiny

Studies exploring whether there’s a connection between Tylenol’s key ingredient acetaminophen and autism have had mixed results.

2 min read
Photo by Marco Verch via CC BY 2.0

Healthcare

Pfizer Built a Covid Empire, But the World Has Moved On

Pfizer’s stock slumped its lowest level in more than 10 years. The world’s moved on from the pandemic, and nobody loves you when you’re down.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.